In a transgenic mouse model, MAP17 hepatic overexpression resulted in PDZK1 (NHeRF3) liver deficiency, suggesting that MAP17 is an endogenous regulator of PDZK1 turnover (Silver et al., 2003). The gene discussed is PDZK1IP1; the disease is hyperinsulinemic hypoglycemia, familial, 4.